BH
Brian Halak
Angel InvestorActiveBrian Halak joined Domain Associates, LLC in 2001 and became a Partner in 2006.He currently serves on the Board of Alimera Sciences, Cartice...
66
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Brian Halak.
Investment Thesis & Strategy
Brian Halak, as an angel investor, likely invests in various stages across different industries, potentially seeking innovative companies with strong growth potential. His experience at Domain Associates suggests a focus on healthcare and life sciences.
Portfolio Companies
Selected investments from their portfolio of 66 companies
A
Aspen Neuroscience
Biotech · Series A, 0
I
Inc.
Other · Seed, 0
C
Cotera
Other · Seed, 0
E
Exalys Therapeutics
Biotech · Seed, 0
A
Adynxx
Other · , 0
T
Tandem Diabetes Care
Other · , 0
I
Immunitas Therapeutics
Other · , 0
G
Glaukos
Other · , 0
O
Oraya Therapeutics
Other · , 0
O
Otonomy
Other · , 0
S
Singular Genomics
Other · , 0
a
aTyr Pharma
Other · , 0
Frequently Asked Questions
Brian Halak focuses on Seed stage investments.
Related Investors
Hart Callahan
Philadelphia, United States · 81 deals
Michael DiPiano
Philadelphia, United States · 81 deals
Andrew Panzo
Philadelphia, United States · 81 deals
Anne Vazquez
Philadelphia, United States · 81 deals
Marc Lederman
Philadelphia, United States · 81 deals
Croom Beatty
Philadelphia, United States · 78 deals